[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335217-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335217-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","neutrophil-to-lymphocyte-ratio-as-a-predictor-of-cardiovascular-mortality-in-cancer-survivors","Neutrophil-to-lymphocyte ratio as a predictor of cardiovascular mortality in cancer survivors","","Neutrophil-to-lymphocyte ratio (NLR) is evaluated as a predictive biomarker for cardiovascular mortality among cancer survivors using NHANES data from 2007–2018. The study analyzes 4,974 cancer survivors and tests prognostic associations for all-cause, cardiovascular, and cancer-specific mortality. Cox regression and Kaplan–Meier analyses identify an optimal NLR cutoff of 2.61, separating higher and lower NLR groups. Elevated NLR independently correlates with higher all-cause and cardiovascular mortality, with effects modified across key subgroups.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/neutrophil-to-lymphocyte-ratio-as-a-predictor-of-cardiovascular-mortality-in-cancer-survivors/335217/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/neutrophil-to-lymphocyte-ratio-as-a-predictor-of-cardiovascular-mortality-in-cancer-survivors/335217.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does this study evaluate as a biomarker for cancer survivors?","Question",{"text":63,"@type":64},"The study evaluates the neutrophil-to-lymphocyte ratio (NLR) as a predictive biomarker for cardiovascular mortality in cancer patients using NHANES data.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many cancer survivors were included, and what was the data source?",{"text":68,"@type":64},"A total of 4,974 cancer survivors with available survival data were included from NHANES, covering 2007–2018.",{"name":70,"@type":61,"acceptedAnswer":71},"What NLR cutoff was identified and what did it indicate?",{"text":72,"@type":64},"An optimal NLR cutoff of 2.61 was identified; higher NLR levels were associated with increased all-cause and cardiovascular mortality in adjusted models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335217,1790788652,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nNeutrophil‑to‑lymphocyte ratio as a predictor of cardiovascular mortality in cancer survivors  \nYan He, Xing Liu, Min Wang, Honghong Ke & Chenliang Ge *  \nThis study aims to evaluate the neutrophil‑to‑lymphocyte ratio (NLR) as a predictive biomarker for cardiovascular mortality among cancer patients, utilizing data from the National Health and Nutrition Examination Survey (NHANES) . From the NHANES dataset (2007–2018), we analyzed 4974 cancer survivors, investigating the prognostic significance of NLR for all‑cause, cardiovascular, and cancer‑ specific mortality. Survival outcomes were analyzed using Cox regression and Kaplan–Meier methods. Optimal NLR cutoffs were identified as 2.61 for differentiating the higher NLR group from lower NLR group. Elevated NLR levels significantly correlated with increased all‑cause mortality (HR 1.11, 95%  \nCI 1.07–1.14, P \u003C 0.001) and cardiovascular mortality (HR 1.14, 95% CI 1.08–1.21, P \u003C 0.001) in adjusted models. Subgroup analyses revealed that age, sex, smoking status, and hypertension significantly influence NLR’s association with cardiovascular mortality. Specific cancers including breast, prostate, non‑melanoma skin, colon and melanoma experience increased all‑cause and cardiovascular mortality in the higher NLR group compared to lower NLR group. Elevated NLR is a significant predictor of increased mortality in cancer patients, particularly for cardiovascular outcomes. These findings support that NLR acts as a pivotal prognostic tool with significant implications for clinical practice in the realm of cardio‑oncology.  \nKeywords NLR, Cardiovascular mortality, Cancer participants, NHANES  \nThe confluence of oncology and cardiology, known as cardio-oncology, has emerged as a critical field of investigation amidst the rising tide of cancer survivorship and the attendant surge in long-term cardiovascular complications 1. While advancements in cancer treatments have extended lives, they have also introduced a spectrum of cardiotoxic effects, particularly through chemotherapy and radiation therapy2. Despite significant strides in delineating the cardiovascular risks facing cancer patients, a glaring lacuna persists in the identification of precise predictors or biomarkers of cardiac mortality within this cohort. This gap highlights an urgent need for innovative methodologies to predict and attenuate the cardiovascular impact of cancer therapies3,4.  \nThe neutrophil-to-lymphocyte ratio (NLR), a straightforward and readily accessible inflammatory marker, has garnered attention for its prognostic significance across various clinical settings5,6. Its elevation is consistently associated with poor outcomes in a range of conditions, from cardiovascular diseases to diverse cancers, underscoring its role in systemic inflammation and immune response modulation7–9. While the prognostic value of NLR in predicting overall mortality in contexts such as breast cancer and coronary heart disease is established, its potential in forecasting cardiac mortality among cancer patients remains underexplored5, 10.  \nConsidering the intricate interplay between inflammation, cancer, and cardiovascular disease, this study posits that NLR could be a pivotal biomarker for identifying cancer patients at an increased risk of cardiac mortality. By harnessing data from the National Health and Nutrition Examination Survey (NHANES), this retrospective cohort study aims to illuminate the association between NLR and cardiac mortality in cancer patients, thus seeking to bridge a critical knowledge gap in cardio-oncology. This endeavor not only furthers our understanding of the biomarkers that could guide clinical decision-making but also heralds a step towards personalized medicine, where indicators like NLR could inform intervention strategies, optimizing outcomes at the nexus of cancer treatment and cardiovascular risk management.  \nDepartment of Ca","cbCaibR3bKVmnCIv","https://ap.wps.com/l/cbCaibR3bKVmnCIv","pdf",1304765,11,"English","# Methods\n## Study population","[{\"question\":\"What does this study evaluate as a biomarker for cancer survivors?\",\"answer\":\"The study evaluates the neutrophil-to-lymphocyte ratio (NLR) as a predictive biomarker for cardiovascular mortality in cancer patients using NHANES data.\"},{\"question\":\"How many cancer survivors were included, and what was the data source?\",\"answer\":\"A total of 4,974 cancer survivors with available survival data were included from NHANES, covering 2007–2018.\"},{\"question\":\"What NLR cutoff was identified and what did it indicate?\",\"answer\":\"An optimal NLR cutoff of 2.61 was identified; higher NLR levels were associated with increased all-cause and cardiovascular mortality in adjusted models.\"}]","Neutrophil-to-lymphocyte ratio as a predictor of cardiovascular mortality in cancer survivors | PDF",1790010195,28]